Form 4 for MRNA Moderna
Accepted 2024-06-17 00:00:00 ET · period of report 2024-06-14 · accession 0001127602-24-018819 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-17 | 2024-06-14 | MRNA | Bancel Stephane | CEO, Dir | J - Other | $0.00 | +26.8K | 5.49M | +0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-14 | J | A | 26,840 | $0.00 | 5,487,064 | D | — | — |